REDDI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 6.463
EU - Europa 582
AS - Asia 401
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 7.452
Nazione #
US - Stati Uniti d'America 6.460
CN - Cina 348
FI - Finlandia 155
IT - Italia 120
SE - Svezia 87
DE - Germania 79
UA - Ucraina 73
GB - Regno Unito 44
IN - India 30
KR - Corea 12
IE - Irlanda 8
FR - Francia 6
VN - Vietnam 5
EU - Europa 4
CA - Canada 3
NL - Olanda 3
RU - Federazione Russa 3
HK - Hong Kong 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
DK - Danimarca 1
GR - Grecia 1
IR - Iran 1
MO - Macao, regione amministrativa speciale della Cina 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
Totale 7.452
Città #
Fairfield 1.149
Woodbridge 666
Chandler 558
Houston 507
Ashburn 495
Seattle 433
Wilmington 414
Jacksonville 390
Cambridge 376
Ann Arbor 314
Princeton 163
San Diego 117
Beijing 111
Medford 87
Des Moines 83
Nanjing 78
Padova 62
Helsinki 51
Boardman 41
Roxbury 31
Nanchang 30
Shenyang 24
Pune 21
Hebei 20
Guangzhou 19
Jiaxing 18
New York 18
Falls Church 14
London 11
Norwalk 10
Redwood City 10
Changsha 9
Ogden 9
Dublin 8
Kharkiv 7
Borås 6
Kilburn 6
Milan 6
Dong Ket 5
Selvazzano Dentro 5
Zhengzhou 5
Dearborn 4
Columbus 3
Jinan 3
Mestrino 3
Ningbo 3
Rockville 3
Washington 3
Auburn Hills 2
Cascina 2
Catania 2
Chicago 2
Chiswick 2
Florence 2
Geislingen an der Steige 2
Haikou 2
Hong Kong 2
Iowa City 2
Kunming 2
Lamezia Terme 2
Naples 2
Paris 2
Prescot 2
Raleigh 2
San Pietro 2
Soeul 2
Tianjin 2
Venice 2
Acton 1
Ancona 1
Ardabil 1
Athens 1
Augusta 1
Bad Muenstereifel 1
Basovizza 1
Berlin 1
Bologna 1
Brussels 1
Bucharest 1
Canberra 1
Chengdu 1
Chioggia 1
Como 1
Durham 1
Esslingen am Neckar 1
Hangzhou 1
Hanover 1
Hounslow 1
Indiana 1
Islington 1
Lanzhou 1
Messina 1
Milton Keynes 1
Moscow 1
Mumbai 1
Munich 1
Napoli 1
Pontiac 1
Portland 1
Québec 1
Totale 6.481
Nome #
Conjugation of photosensitisers to antimicrobial peptides increases the efficiency of photodynamic therapy in cancer cells 137
The cellular uptake of meta-tetra(hydroxyphenyl) chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins. 136
Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. 130
Highly PEGylated silica nanoparticles: ready to use stealth functional nanocarriers 117
Molecular targets of antimicrobial photodynamic therapy identified by a proteomic approach. 114
Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids 113
Mechanism of Action of 4-Hydroxymethyl-1,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one, a Very Active Angular Furocoumarin-like Sensitizer 110
PEGylation of ORMOSIL nanoparticles differently modulates the in vitro toxicity toward human lung cells 109
Bronze Baby Syndrome: An Animal Model 105
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 99
Meso-substituted tetra-cationic porphyrins photosensitize the death of human fibrosarcoma cells via lysosomal targeting 98
Procoagulant properties of bare and highly-PEGylated vinyl-modified silica nanoparticles 98
THE EFFECTS OF PORPHYRIN STRUCTURE AND AGGREGATION STATE ON PHOTOSENSITIZED PROCESSES IN AQUEOUS AND MICELLAR MEDIA 93
Keratin nanoparticles co-delivering Docetaxel and Chlorin e6 promote synergic interaction between chemo- and photo-dynamic therapies 92
Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation. 91
Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: characterisation, in vitro cellular uptake and phototoxicity 90
Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer 90
Cyclodextrin-assisted assembly of PEGylated polyester nanoparticles decorated with folate 88
The toxicity outcome of silica nanoparticles (Ludox®) is influenced by testing techniques and treatment modalities 87
Spectroscopic studies on Zn(II)-phthalocyanine in homogeneous and microheterogeneous systems. 87
A comparative study on two cationic porphycenes: Photophysical and antimicrobial photoinactivation evaluation 87
Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats. 85
In vitro phototoxicity of phenothiazines: Involvement of stable UVA photolysis products formed in aqueous medium 84
Synthesis, Characterization, and Photoinduced Antibacterial Activity of Porphyrin-Type Photosensitizers Conjugated to the Antimicrobial Peptide Apidaecin 1b 84
The cellular uptake of meta-tetra (hydroxyphenyl) chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins 83
In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy 82
Porphyrin−Apidaecin Conjugate as a New Broad Spectrum Antibacterial Agent 80
PHOTOKINETIC AND PHOTOPHYSICAL MEASUREMENTS OF THE SENSITIZED PHOTOOXIDATION OF THE TRYPTOPHYL RESIDUE IN N-ACETYL TRYPTOPHANAMIDE AND IN HUMAN SERUM ALBUMIN 80
Polylysine-porphycene conjugates as efficient photosensitizers for the inactivation of microbial pathogens 79
ROLE OF SPECIFIC CELLULAR TARGETS IN THE HEMATOPORPHYRIN-SENSITIZED PHOTOINACTIVATION OF MICROBIAL CELLS 79
Delivery of the tumour photosensitizer zinc(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo. 79
ULTRASTRUCTURAL STUDIES ON THE MECHANISM OF THE PHOTODYNAMIC THERAPY OF TUMORS 79
"Modeled microgravity" affects cell response to ionizing radiation and increases genomic damage 78
Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice. 78
Carotenoporphyrins as selective photodiagnostic agents for tumours 76
Pluronic® mixed micelles as efficient nanocarriers for benzoporphyrin derivatives applied to photodynamic therapy in cancer cells 76
Factors governing the mechanism and efficiency of porphyrin-sensitized photooxidations in homogeneous solutions and organized media. 75
A COMPARISON OF FLUORESCENCE METHODS USED IN THE PHARMACOKINETIC STUDIES OF Zn(II)PHTHALOCYANINE IN MICE 75
Organically-modified silica nanoparticles for the delivery of meta-tetra(hydroxyphenyl)chlorin 74
Photothermal sensitization of amelanotic melanoma cells by Ni(II)-octabutoxy-naphthalocyanine 74
Laser-induced fluorescence in malignant and normal tissue in mice injected with two different carotenoporphyrins 74
Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)chlorin (m-THPC) 74
Interaction of human serum albumin with hematoporphyrin and its Zn(2)+-and Fe(3)+-derivatives. 73
Nanovehicles loaded with meta-tetra(hydroxyphenyl)chlorine for photodynamic treatment of cancer 72
Bronze baby syndrome: evidence for increased serum porphyrin concentration. 72
Factors influencing the haematoporphyrin-sensitized photoinactivation of Candida albicans. 71
Bronze baby syndrome: a new porphyrin-related disorder. 70
Photosensitization with zinc(II)phthalocyanine as a switch in the decision between apoptosis and necrosis 69
Biodegradable nanoparticles exposing a short anti-FLT1 peptide as antiangiogenic platform to complement docetaxel anticancer activity 69
Pharmacokinetic and phototherapeutic properties of axially substituted Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines 68
The Photochemistry of Carotenoids: Some Photosynthetic and Photomedical Aspects 66
STUDIES ON THE MECHANISM OF THE HEMATOPORPHYRIN-SENSITIZED PHOTOOXIDATION OF 1,3-DIPHENYLISOBENZOFURAN IN ETHANOL and UNILAMELLAR LIPOSOMES 66
Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells 66
Peptoid scan in antimicrobial peptides: synthesis and antibacterial activity of [Narg]peptoid-peptide hybrids of apidaecin Ib 65
Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency 65
Steady state and time-resolved spectroscopic studies on zinc(II) phthalocyanine in liposomes 64
Effect of extracellularly generated singlet oxygen on Gram-positive and Gram-negative bacteria 64
Pegylated ORMOSIL nanoparticles as potential nanocarriers of photodynamic agents for tumours. 64
Skin-photosensitizing properties of Zn(II)-2(3), 9(10), 16(17), 23(24)-tetrakis-(4-oxy-N-methylpiperidinyl) phthalocyanine topically administered to mice 63
Synthesis, Spectroscopic and Photophysical Characterization and Photosensitizing Activity Toward Prokaryotic and Eukaryotic Cells of Porphyrin-Magainin and –Buforin Conjugates 63
Mitochondria and plasma membrane as targets of UVA-induced toxicity of neuroleptic drugs fluphenazine, perphenazine and thioridazine 63
The production of singlet molecular oxygen by zinc(II) phthalocyanine in ethanol and in unilamellar vesicles. Chemical quenching and phosphorescence studies. 63
Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours. 62
Low doses of cisplatin or gemcitabine plus Photofrin-photodynamic therapy: disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). 62
Photochemical and photosensitizing properties of monomeric and dimeric Sn(IV)-protoporphyrin 61
Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine 60
Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice. 59
Structural and functional differences between fetal and adult serum albumin. 59
UNUSUALLY HIGH-AFFINITY OF ZN(II)-TETRADIBENZOBARRELENOOCTABUTOXY-PHTHALOCYANINE FOR LOW-DENSITY LIPOPROTEINS IN A TUMOR-BEARING MOUSE 58
The distribution of the tumour photosensitizers Zn(II)-phthalocyanine and Sn(IV)-etiopurpurin among rabbit plasma proteins. 58
The role of lipoproteins in the delivery of tumour-targeting photosensitizers 56
Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells 55
Strategies for optimizing the delivery to tumors of macrocyclic photosensitizers used in photodynamic therapy (PDT) 55
Interaction of hydro- or lipophilic phthalocyanines with cells of different metastatic potential 54
Antitumor activity of photodynamic therapy, adoptive immunotherapy and chemotherapy in experimental tumor 53
Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts 52
Steady-state and time-resolved spectroscopic studies on low-density lipoprotein-bound Zn(II)-phthalocyanine 52
PDT with Photofrin does not enhance cisplatin cytotoxicity in oesophageal cancer cells. 50
Organic-modified silica (Ormosil) nanoparticles for the delivery of photosensitizers to cancer cells. 50
CD44 targeting mediated by polymeric nanoparticles and combination of chlorine TPCS2a-pdt and docetaxel-chemotherapy for efficient killing of breast differentiated and stem cancer cells in vitro 50
Effect of UV-irradiation on cell cycle checkpoints in human lymphocytes and in lymphoblastoid cells. 48
Effect of the delivery system on the biodistribution of Ge(IV)-octabutoxy-phthalocyanines in tumour-bearing mice. 48
THE PRODUCTION OF SINGLET MOLECULAR OXYGEN BY ZINC(II) PHTHALOCYANINE IN ETHANOL AND IN UNILAMELLAR VESICLES. CHEMICAL QUENCHING AND PHOSPHORESCENCE STUDIES 47
Laser-induced fluorescence studies of the biodistribution of carotenoporphyrins in mice 47
Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin combined with photodynamic therapy. 45
Antimicrobial peptide-porphyrin conjugates: new tools in photodynamic therapy 45
"Nanosistemi per ottimizzare la terapia fotodinamica dei tumori: vantaggi e limitazioni" 44
Cytotoxicity and genotoxicity induced in human cells incubated with commercial nanomaterials 43
Nanovehicles loaded with meta-tetra(hydroxyphenyl)chlorin for photodynamic treatment of cancer 43
"PEGylated ORMOSIL nanoparticles for improved delivery of photosensitisers used in photodynamic therapy" 42
Shedding light on surface exposition of poly(ethylene glycol) and folate targeting units on nanoparticles of poly(ε-caprolactone) diblock copolymers: Beyond a paradigm 42
"Delivery of meta-tetra(hydroxyphenyl)chlorine (mTHPC) in organically-modified silica (ORMOSIL) nanoparticles to cancer cells" 41
THE EFFECT OF MEDIUM POLARITY ON THE HEMATOPORPHYRIN-SENSITIZED PHOTOOXIDATION OF l-TRYPTOPHAN 40
Organic modified silica (Ormosil) nanoparticles for the delivery of photosensitizer mTHPC to cancer cells. 38
Interaction between chemotherapy and photodynamic therapy in esophageal and lung cancer cells. 37
Keratin nanoparticles and photodynamic therapy enhance the anticancer stem cells activity of salinomycin 37
PORPHYRIN-TYPE PHOTOSENSITISERS FOR KILLING BACTERIA AND CANCER CELLS WITH PHOTODYNAMIC THERAPY 36
"PEGylated liposomes for the delivery of hydrophobic photosensitizers" 35
Photosensitization of cells with different metastatic potential by liposome-delivered Zn(II)-phthalocyanine 33
Cytotoxic effects induced by the combination of chemotherapy and PDT in tumour cells in vitro 32
Totale 6.984
Categoria #
all - tutte 25.956
article - articoli 22.275
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 106
patent - brevetti 0
selected - selezionate 0
volume - volumi 228
Totale 48.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019711 0 0 0 0 0 0 0 0 0 157 310 244
2019/20201.700 298 55 39 109 176 139 155 193 171 183 101 81
2020/20211.318 43 86 22 105 239 98 18 137 189 143 191 47
2021/20221.377 47 230 139 69 66 78 101 144 62 41 150 250
2022/20231.076 247 111 35 108 184 146 2 78 110 1 38 16
2023/2024428 19 104 78 45 36 58 41 21 22 4 0 0
Totale 7.506